CIENCIASMEDICASNEWS: Multiplexed Screening of a Kinase Library for TCR Signaling Inhibition

viernes, 26 de abril de 2019

Multiplexed Screening of a Kinase Library for TCR Signaling Inhibition

	April 24, 2019
	Immunology
	The latest immunology news from News Medical

Multiplexed Screening of a Kinase Library for TCR Signaling Inhibition
Kinase inhibitor drugs specifically targeting early signaling events during T cell activation are a new focus for the treatment of autoimmune diseases. The development of these drugs and therapies regulating TCR activity require assays that can rapidly profile T cell function and health.

Learn about a novel assay used to evaluate a library of kinase inhibitors by simultaneous measurement of activation markers, cell proliferation and cytokines in a single well

Download Application Note

			People born with short telomeres found to have short-lived immune system cells Scientists at Johns Hopkins say they have found that people born with abnormally short chromosome endcaps, or telomeres, have immune system cells that age and die prematurely.

			Study uncovers details about human immune response to dengue infection About 40 percent of the global population is at risk for contracting dengue - the most important mosquito-borne viral infection and a close "cousin" of the Zika virus - and yet, no effective treatment or safe licensed vaccine exists.

	Removing damaged mitochondria may relieve chronic inflammatory conditions Researchers have discovered a potential new way to treat chronic inflammatory diseases, by eliminating damaged mitochondria before they trigger excessive inflammation.

	Study reveals immune evasion strategy developed by cytomegaloviruses Owl monkey cytomegalovirus produces a decoy molecule A43 to evade detection and destruction by immune cells in their hosts, according to a study published April 4 in the open-access journal PLOS Pathogens by Ana Angulo of the University of Barcelona, and colleagues.

	Innate immune sensor responding to gut microbes can suppress liver cancer UT Southwestern researchers have found that a protein in the body's innate immune system that responds to gut microbes can suppress the most common type of liver cancer.

	Three studies show how tumors hijack the immune system to develop radiotherapy resistance More than a decade ago, radiation oncologists noticed a nifty phenomenon: Sometimes radiation used locally against a tumor could excite the immune system to attack cancer systemically throughout the body.